LMO7 Activators represent a class of chemical compounds that have garnered significant attention in the realm of molecular biology and cellular physiology. These activators are specifically designed to modulate the function of LMO7, a multifunctional protein that plays a crucial role in various cellular processes. LMO7, short for LIM domain only protein 7, is known for its involvement in cytoskeletal organization, cell adhesion, and intracellular signaling pathways. It contains multiple LIM domains, which are protein-binding motifs that mediate interactions with various partner proteins. LMO7 is predominantly expressed in tissues with high mechanical stress, such as cardiac and skeletal muscles, where it plays a critical role in maintaining the structural integrity of cells.
LMO7 Activators function by binding to specific regions of the LMO7 protein, leading to conformational changes that either enhance or inhibit its activity. These small molecules have the potential to fine-tune LMO7's functions, thereby influencing cellular processes regulated by this protein. By modulating LMO7, these activators can impact critical cellular events like cytoskeletal remodeling, cell adhesion, and signal transduction. Consequently, researchers are exploring the implications of LMO7 Activators in various biological contexts, ranging from understanding the mechanisms underlying tissue development and homeostasis to investigating their role in diseases associated with aberrant cytoskeletal dynamics and cell adhesion.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate signaling pathways involving LMO7. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, potentially influencing pathways that intersect with LMO7. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3, which may have downstream effects on LMO7-related pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences gene expression and may impact genes regulated by or regulating LMO7. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone influences gene expression and could indirectly affect LMO7's role in transcription. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, which might influence cytoskeletal dynamics and potentially intersect with LMO7. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, potentially affecting pathways related to LMO7's functions. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 inhibits TGF-β signaling, which could intersect with LMO7-related pathways. | ||||||